ClinicalTrials.gg
RecruitingNCT06253728COBRAUpdated Feb 12, 2024

A Study of Biochemical Response to Alternative Proteins

An interventional study of High fiber and protein meal and Control in Postprandial Hyperglycemia, Overweight and Obesity and Type2diabetes, sponsored by University of Eastern Finland. Recruiting at 1 site in Finland. Open to participants aged 30 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-02-12.

Sponsored by University of Eastern Finland · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 5 months ago, but the record still lists the study as recruiting.
  • Started Jan 2024; still recruiting 2 years 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
30 Years to 65 Years
Sex
All
01

Study summary

The overall objective of this research is to determine the digestive faith and health impact of protein and fiber rich foods in different food matrices in type 2 diabetes risk population. This is achieved by controlled postprandial intervention where plasma amino acids, lipids, glucose metabolism, bile acids and microbial metabolites are evaluated as well as fecal microbiota and metabolites.

Read the detailed description

Detailed research aim of this controlled, randomized crossover postprandial clinical study are:

  1. To study the impact of complex plant- and animal-based foods on glucose metabolism, acute inflammation, and markers of microbial fermentation of fiber and proteins.
  2. To investigate the difference in the gut mediated metabolism induced by naturally occurring fiber fraction bound plant protein or by plant protein with added fiber when compared to animal protein.
  3. To conduct in vitro experiments using fecal samples from participants in the meal study to investigate the distinctions between different animal and plant proteins on both host and microbial metabolites, as well as the function of the gut barrier.
02

Conditions studied

  • Postprandial Hyperglycemia
  • Overweight and Obesity
  • Type2diabetes
03

In context

Hyperglycemia

800 studies on the registry are indexed under Hyperglycemia; 115 are open to participants now.

This study's planned enrollment of 24 is below the median of 50 across 620 interventional studies indexed under Hyperglycemia.

Browse Hyperglycemia studies →

Lead sponsor

University of Eastern Finland is the lead sponsor of 54 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 30-65 years of age
  • >25 kg/m2 and \<35 kg/m2
  • Waist circumference with females >85 cm and with males >100 cm

Exclusion criteria

Exclusion Criteria:

  • Certain chronic diseases requiring regular medication (e.g., type 2 diabetes, chronic liver, kidney, thyroid, or gastrointestinal diseases)
  • Pregnancy or breastfeeding
  • Gluten-free or vegan diet
  • Use of antibiotics within the last 12 months
  • Gastrointestinal surgery within the last two years
  • High alcohol consumption
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Meal 1

    Meal with plant protein and fiber in an intact structure

    Dietary Supplement: High fiber and protein meal

  • Experimental
    Meal 2

    Meal with plant protein and fiber, where the cell structure is broken

    Dietary Supplement: High fiber and protein meal

  • Placebo comparator
    Meal 3

    Low protein and low fiber cereal

    Dietary Supplement: Control

  • Experimental
    Meal 4

    High protein and low carbohydrate bread with animal proteins

    Dietary Supplement: High fiber and protein meal

  • Experimental
    Meal 5

    High protein and low carbohydrate bread with plant protein

    Dietary Supplement: High fiber and protein meal

Interventions

  • Dietary supplementHigh fiber and protein meal

    In the intervention participants are assigned to eat high protein and fiber meal that differ in protein source or structure.

  • Dietary supplementControl

    The control meal is low fiber and low protein meal.

06

What researchers measure

Primary outcomes

  1. Plasma amino acids

    Plasma free amino acids were measured at 0, 30, 60, 90, 180, and 240 minutes after consuming the study meal.

    Time frame: 0-4 hours

  2. Gut derived metabolites

    Gut derived metabolites are measured with untargeted metabolomics from plasma at 12 hours after consuming the study meal. From fecal sample, the metabolomics are measured at 24 hours after consuming the study meal. Plasma short chain fatty acids are quantified at 12 hours after consuming the study meal.

    Time frame: 0-24 hours

Secondary outcomes

  1. Plasma glucose

    Plasma glucose is measured at 0, 30, 60, 90, 180, and 240 minutes after consuming the study meal.

    Time frame: 0-4 hours

  2. Inflammation marker

    Plasma IL-22 is measured at 0, 60, 240 minutes after consuming the study meal.

    Time frame: 0-4 hours

  3. Plasma triglycerides

    Plasma triglycerides are measured at 0, 30, 60, 90, 180, and 240 minutes after consuming the study meal.

    Time frame: 0-4 hours

  4. Urine para-cresol

    The amount of para-cresol is measured from urine sample at 24 hours after consuming the study meal.

    Time frame: 24 hours

  5. Plasma insulin

    Plasma insulin is measured at 0, 30, 60, 90, 180, and 240 minutes after consuming the study meal.

    Time frame: 0-4 hours

  6. Plasma free fatty acids

    Plasma free fatty acids are measured at 0, 30, 60, 90, 180, and 240 minutes after consuming the study meal.

    Time frame: 0-4 hours

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06253728
Lead sponsor
University of Eastern Finland
Responsible party
Sponsor
First posted
Feb 12, 2024
Start date
Jan 18, 2024
Primary completion
Jun 3, 2024 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Feb 12, 2024

Study contacts

Marjukka Kolehmainen, Professor
Contact
marjukka.kolehmainen@uef.fi
0403553617
Moona Partanen, Msc
Contact
moona.partanen@uef.fi
+358 504759536
Marjukka Kolehmainen, Professor
principal investigator · University of Eastern Finland

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion